Global Cryonics Technology
Global Cryonics Technology

Cryonics Technology Comprehensive Study by Application (Animal Husbandry, Conserving Plant Biodiversity, Fishery Science, Medical Science, Preservation of Microbiology Culture), By End User (Research Laboratories, Life Science and Healthcare Facilities), By Methods (Ultra-Rapid, Vitrification, Slow Freezing), By Cryoprotective Agent (Permeating Cryoprotectants Agent, Non-Permeating Cryoprotectants Agent) Players and Region - Global Market Outlook to 2026

Cryonics Technology Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Sep 2021 Edition 202 Pages 220 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Cryonics Technology Market Overview:
Cryonics is the practice of preserving human bodies in extremely cold temperatures by cooling people after death instantly, up to the range where molecular physical decay completely stops, and in such a situation patient is held in a state of cryonic suspension. Cryonics technology is utilized for the preservation & safeguarding of living cells and tissues at extremely low temperatures. Cryonics technology is embraced by clinical areas to save living body organs which can help the interest of this technology. Government interest in clinical areas and expanding deaths brought about by incurable diseases are the significant driving variable for this industry. There is an expansion in organ relocates medical procedures nowadays is a key powerhouse for the development of the cryonics technology market.

Growth Drivers
  • Growing adoption of technology in the preservation of living cells
  • The rise in the rate of death caused due by incurable diseases
  • Increase in demand for organ transplantation across the globe

Roadblocks
  • Lack of qualified/skilled medical practitioners across the globe
  • Slow adoption of technology in developing countries as there is a lack of technology infrastructure

Opportunities
  • Growing demand for preservation of endangered species and stop the aging process
  • Increase continuous research in encode memories from preserved brain
  • The rise in demand for egg and sperm preservation

Challenges
  • Follow the rules and regulations of different regions
  • High initial investment requirement for application of cryonics technology


Competitive Landscape:
The Cryonics Technology market is engaged with different size organizations. The giant organization is focusing on research and development activities related to cryonics technology. Moreover, companies are a collaboration with different hospitals, biomedical laboratories across the globe.
Some of the key players profiled in the report are Cellulis (Spain), Cryofab (United States), Cryologics (United States), Cryotherm (Germany), Custom Biogenic Systems (United States), GE Healthcare (United States), Panasonic Biomedical (Japan), PBS Group (United States), Praxair Technology (United States) and Thermo Fisher Scientific (United States). Additionally, following companies can also be profiled that are part of our coverage like KrioRus (Russia), Oregon Cryonics (United States) and VWR (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Cryonics Technology market by 2026. Considering Market by By End User, the sub-segment i.e. Research Laboratories will boost the Cryonics Technology market. Considering Market by By Methods, the sub-segment i.e. Ultra-Rapid will boost the Cryonics Technology market. Considering Market by By Cryoprotective Agent, the sub-segment i.e. Permeating Cryoprotectants Agent will boost the Cryonics Technology market.

Latest Market Insights:
On 16 February 2021, Chart Industries, Inc. announced the acquisition of Cryogenic Gas Technologies, Inc. Cryo Technologies is a global leader in custom-engineered process systems to separate, purify, refrigerate, liquefy and distribute high-value industrial gases such as hydrogen, helium, argon, and hydrocarbons with design capabilities for cold boxes for hydrogen and helium use. Through this acquisition, they differentiated cryogenic engineering expertise by global project experience in hydrogen and helium liquefaction coupled with our process technologies.

On 12 November 2019, BioLife Solutions, Inc., a leading developer, and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, announced the acquisition of substantially all of the assets of Custom Biogenic Systems, Inc. CBS, a privately held company with operations located near Detroit, is a global leader in the design and manufacture of state-of-the-art liquid nitrogen laboratory freezers and cryogenic equipment. The acquisition of CBS will allow to deepen engagement with cell and gene therapy customers and increase touchpoints in their manufacturing, storage, and distribution workflows.

What Can be Explored with the Cryonics Technology Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Cryonics Technology Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Cryonics Technology
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Cryonics Technology market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Cryonics Technology market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Government Regulatory Bodies, Government Research Institutions, Private Research Institutions, Cryonics Technology Manufacturers, Cryonics Technology Suppliers and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global Cryonics Technology Market?
The Cryonics Technology market is expected to see a CAGR of % during projected year 2020 to 2026.

2. Who are the top performing companies in Cryonics Technology Market?
Top performing companies in the Global Cryonics Technology market are Cellulis (Spain), Cryofab (United States), Cryologics (United States), Cryotherm (Germany), Custom Biogenic Systems (United States), GE Healthcare (United States), Panasonic Biomedical (Japan), PBS Group (United States), Praxair Technology (United States) and Thermo Fisher Scientific (United States), to name a few.

3. What trending factors would impact Cryonics Technology Market growth most?
"Increase in the technology advancement regarding the cryonics technology in developed countries " is seen as one of major influencing trends for Cryonics Technology Market during projected period 2020-2026.

Report Objectives / Segmentation Covered
By Application
  • Animal Husbandry
  • Conserving Plant Biodiversity
  • Fishery Science
  • Medical Science
  • Preservation of Microbiology Culture
By By End User
  • Research Laboratories
  • Life Science and Healthcare Facilities

By By Methods
  • Ultra-Rapid
  • Vitrification
  • Slow Freezing

By By Cryoprotective Agent
  • Permeating Cryoprotectants Agent
  • Non-Permeating Cryoprotectants Agent

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing adoption of technology in the preservation of living cells
      • 3.2.2. The rise in the rate of death caused due by incurable diseases
      • 3.2.3. Increase in demand for organ transplantation across the globe
    • 3.3. Market Challenges
      • 3.3.1. Follow the rules and regulations of different regions
      • 3.3.2. High initial investment requirement for application of cryonics technology
    • 3.4. Market Trends
      • 3.4.1. Increase in the technology advancement regarding the cryonics technology in developed countries
      • 3.4.2. Increase in government investment and spending budget in the medical sector for research and development for reanimation
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cryonics Technology, by Application, By End User, By Methods, By Cryoprotective Agent and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Cryonics Technology (Value)
      • 5.2.1. Global Cryonics Technology by: Application (Value)
        • 5.2.1.1. Animal Husbandry
        • 5.2.1.2. Conserving Plant Biodiversity
        • 5.2.1.3. Fishery Science
        • 5.2.1.4. Medical Science
        • 5.2.1.5. Preservation of Microbiology Culture
      • 5.2.2. Global Cryonics Technology by: By End User (Value)
        • 5.2.2.1. Research Laboratories
        • 5.2.2.2. Life Science and Healthcare Facilities
      • 5.2.3. Global Cryonics Technology by: By Methods (Value)
        • 5.2.3.1. Ultra-Rapid
        • 5.2.3.2. Vitrification
        • 5.2.3.3. Slow Freezing
      • 5.2.4. Global Cryonics Technology by: By Cryoprotective Agent (Value)
        • 5.2.4.1. Permeating Cryoprotectants Agent
        • 5.2.4.2. Non-Permeating Cryoprotectants Agent
      • 5.2.5. Global Cryonics Technology Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Cryonics Technology (Price)
  • 6. Cryonics Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cellulis (Spain)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cryofab (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cryologics (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cryotherm (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Custom Biogenic Systems (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GE Healthcare (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Panasonic Biomedical (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PBS Group (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Praxair Technology (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Thermo Fisher Scientific (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Cryonics Technology Sale, by Application, By End User, By Methods, By Cryoprotective Agent and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Cryonics Technology (Value)
      • 7.2.1. Global Cryonics Technology by: Application (Value)
        • 7.2.1.1. Animal Husbandry
        • 7.2.1.2. Conserving Plant Biodiversity
        • 7.2.1.3. Fishery Science
        • 7.2.1.4. Medical Science
        • 7.2.1.5. Preservation of Microbiology Culture
      • 7.2.2. Global Cryonics Technology by: By End User (Value)
        • 7.2.2.1. Research Laboratories
        • 7.2.2.2. Life Science and Healthcare Facilities
      • 7.2.3. Global Cryonics Technology by: By Methods (Value)
        • 7.2.3.1. Ultra-Rapid
        • 7.2.3.2. Vitrification
        • 7.2.3.3. Slow Freezing
      • 7.2.4. Global Cryonics Technology by: By Cryoprotective Agent (Value)
        • 7.2.4.1. Permeating Cryoprotectants Agent
        • 7.2.4.2. Non-Permeating Cryoprotectants Agent
      • 7.2.5. Global Cryonics Technology Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Cryonics Technology (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cryonics Technology: by Application(USD Million)
  • Table 2. Cryonics Technology Animal Husbandry , by Region USD Million (2015-2020)
  • Table 3. Cryonics Technology Conserving Plant Biodiversity , by Region USD Million (2015-2020)
  • Table 4. Cryonics Technology Fishery Science , by Region USD Million (2015-2020)
  • Table 5. Cryonics Technology Medical Science , by Region USD Million (2015-2020)
  • Table 6. Cryonics Technology Preservation of Microbiology Culture , by Region USD Million (2015-2020)
  • Table 7. Cryonics Technology: by By End User(USD Million)
  • Table 8. Cryonics Technology Research Laboratories , by Region USD Million (2015-2020)
  • Table 9. Cryonics Technology Life Science and Healthcare Facilities , by Region USD Million (2015-2020)
  • Table 10. Cryonics Technology: by By Methods(USD Million)
  • Table 11. Cryonics Technology Ultra-Rapid , by Region USD Million (2015-2020)
  • Table 12. Cryonics Technology Vitrification , by Region USD Million (2015-2020)
  • Table 13. Cryonics Technology Slow Freezing , by Region USD Million (2015-2020)
  • Table 14. Cryonics Technology: by By Cryoprotective Agent(USD Million)
  • Table 15. Cryonics Technology Permeating Cryoprotectants Agent , by Region USD Million (2015-2020)
  • Table 16. Cryonics Technology Non-Permeating Cryoprotectants Agent , by Region USD Million (2015-2020)
  • Table 17. South America Cryonics Technology, by Country USD Million (2015-2020)
  • Table 18. South America Cryonics Technology, by Application USD Million (2015-2020)
  • Table 19. South America Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 20. South America Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 21. South America Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 22. Brazil Cryonics Technology, by Application USD Million (2015-2020)
  • Table 23. Brazil Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 24. Brazil Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 25. Brazil Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 26. Argentina Cryonics Technology, by Application USD Million (2015-2020)
  • Table 27. Argentina Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 28. Argentina Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 29. Argentina Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 30. Rest of South America Cryonics Technology, by Application USD Million (2015-2020)
  • Table 31. Rest of South America Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 32. Rest of South America Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 33. Rest of South America Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 34. Asia Pacific Cryonics Technology, by Country USD Million (2015-2020)
  • Table 35. Asia Pacific Cryonics Technology, by Application USD Million (2015-2020)
  • Table 36. Asia Pacific Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 37. Asia Pacific Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 38. Asia Pacific Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 39. China Cryonics Technology, by Application USD Million (2015-2020)
  • Table 40. China Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 41. China Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 42. China Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 43. Japan Cryonics Technology, by Application USD Million (2015-2020)
  • Table 44. Japan Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 45. Japan Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 46. Japan Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 47. India Cryonics Technology, by Application USD Million (2015-2020)
  • Table 48. India Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 49. India Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 50. India Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 51. South Korea Cryonics Technology, by Application USD Million (2015-2020)
  • Table 52. South Korea Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 53. South Korea Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 54. South Korea Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 55. Taiwan Cryonics Technology, by Application USD Million (2015-2020)
  • Table 56. Taiwan Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 57. Taiwan Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 58. Taiwan Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 59. Australia Cryonics Technology, by Application USD Million (2015-2020)
  • Table 60. Australia Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 61. Australia Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 62. Australia Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Cryonics Technology, by Application USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 67. Europe Cryonics Technology, by Country USD Million (2015-2020)
  • Table 68. Europe Cryonics Technology, by Application USD Million (2015-2020)
  • Table 69. Europe Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 70. Europe Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 71. Europe Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 72. Germany Cryonics Technology, by Application USD Million (2015-2020)
  • Table 73. Germany Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 74. Germany Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 75. Germany Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 76. France Cryonics Technology, by Application USD Million (2015-2020)
  • Table 77. France Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 78. France Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 79. France Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 80. Italy Cryonics Technology, by Application USD Million (2015-2020)
  • Table 81. Italy Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 82. Italy Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 83. Italy Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 84. United Kingdom Cryonics Technology, by Application USD Million (2015-2020)
  • Table 85. United Kingdom Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 86. United Kingdom Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 87. United Kingdom Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 88. Netherlands Cryonics Technology, by Application USD Million (2015-2020)
  • Table 89. Netherlands Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 90. Netherlands Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 91. Netherlands Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 92. Rest of Europe Cryonics Technology, by Application USD Million (2015-2020)
  • Table 93. Rest of Europe Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 94. Rest of Europe Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 95. Rest of Europe Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 96. MEA Cryonics Technology, by Country USD Million (2015-2020)
  • Table 97. MEA Cryonics Technology, by Application USD Million (2015-2020)
  • Table 98. MEA Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 99. MEA Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 100. MEA Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 101. Middle East Cryonics Technology, by Application USD Million (2015-2020)
  • Table 102. Middle East Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 103. Middle East Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 104. Middle East Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 105. Africa Cryonics Technology, by Application USD Million (2015-2020)
  • Table 106. Africa Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 107. Africa Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 108. Africa Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 109. North America Cryonics Technology, by Country USD Million (2015-2020)
  • Table 110. North America Cryonics Technology, by Application USD Million (2015-2020)
  • Table 111. North America Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 112. North America Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 113. North America Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 114. United States Cryonics Technology, by Application USD Million (2015-2020)
  • Table 115. United States Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 116. United States Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 117. United States Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 118. Canada Cryonics Technology, by Application USD Million (2015-2020)
  • Table 119. Canada Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 120. Canada Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 121. Canada Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 122. Mexico Cryonics Technology, by Application USD Million (2015-2020)
  • Table 123. Mexico Cryonics Technology, by By End User USD Million (2015-2020)
  • Table 124. Mexico Cryonics Technology, by By Methods USD Million (2015-2020)
  • Table 125. Mexico Cryonics Technology, by By Cryoprotective Agent USD Million (2015-2020)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Cryonics Technology: by Application(USD Million)
  • Table 137. Cryonics Technology Animal Husbandry , by Region USD Million (2021-2026)
  • Table 138. Cryonics Technology Conserving Plant Biodiversity , by Region USD Million (2021-2026)
  • Table 139. Cryonics Technology Fishery Science , by Region USD Million (2021-2026)
  • Table 140. Cryonics Technology Medical Science , by Region USD Million (2021-2026)
  • Table 141. Cryonics Technology Preservation of Microbiology Culture , by Region USD Million (2021-2026)
  • Table 142. Cryonics Technology: by By End User(USD Million)
  • Table 143. Cryonics Technology Research Laboratories , by Region USD Million (2021-2026)
  • Table 144. Cryonics Technology Life Science and Healthcare Facilities , by Region USD Million (2021-2026)
  • Table 145. Cryonics Technology: by By Methods(USD Million)
  • Table 146. Cryonics Technology Ultra-Rapid , by Region USD Million (2021-2026)
  • Table 147. Cryonics Technology Vitrification , by Region USD Million (2021-2026)
  • Table 148. Cryonics Technology Slow Freezing , by Region USD Million (2021-2026)
  • Table 149. Cryonics Technology: by By Cryoprotective Agent(USD Million)
  • Table 150. Cryonics Technology Permeating Cryoprotectants Agent , by Region USD Million (2021-2026)
  • Table 151. Cryonics Technology Non-Permeating Cryoprotectants Agent , by Region USD Million (2021-2026)
  • Table 152. South America Cryonics Technology, by Country USD Million (2021-2026)
  • Table 153. South America Cryonics Technology, by Application USD Million (2021-2026)
  • Table 154. South America Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 155. South America Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 156. South America Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 157. Brazil Cryonics Technology, by Application USD Million (2021-2026)
  • Table 158. Brazil Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 159. Brazil Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 160. Brazil Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 161. Argentina Cryonics Technology, by Application USD Million (2021-2026)
  • Table 162. Argentina Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 163. Argentina Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 164. Argentina Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 165. Rest of South America Cryonics Technology, by Application USD Million (2021-2026)
  • Table 166. Rest of South America Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 167. Rest of South America Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 168. Rest of South America Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 169. Asia Pacific Cryonics Technology, by Country USD Million (2021-2026)
  • Table 170. Asia Pacific Cryonics Technology, by Application USD Million (2021-2026)
  • Table 171. Asia Pacific Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 172. Asia Pacific Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 173. Asia Pacific Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 174. China Cryonics Technology, by Application USD Million (2021-2026)
  • Table 175. China Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 176. China Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 177. China Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 178. Japan Cryonics Technology, by Application USD Million (2021-2026)
  • Table 179. Japan Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 180. Japan Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 181. Japan Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 182. India Cryonics Technology, by Application USD Million (2021-2026)
  • Table 183. India Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 184. India Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 185. India Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 186. South Korea Cryonics Technology, by Application USD Million (2021-2026)
  • Table 187. South Korea Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 188. South Korea Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 189. South Korea Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 190. Taiwan Cryonics Technology, by Application USD Million (2021-2026)
  • Table 191. Taiwan Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 192. Taiwan Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 193. Taiwan Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 194. Australia Cryonics Technology, by Application USD Million (2021-2026)
  • Table 195. Australia Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 196. Australia Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 197. Australia Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 198. Rest of Asia-Pacific Cryonics Technology, by Application USD Million (2021-2026)
  • Table 199. Rest of Asia-Pacific Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 200. Rest of Asia-Pacific Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 201. Rest of Asia-Pacific Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 202. Europe Cryonics Technology, by Country USD Million (2021-2026)
  • Table 203. Europe Cryonics Technology, by Application USD Million (2021-2026)
  • Table 204. Europe Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 205. Europe Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 206. Europe Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 207. Germany Cryonics Technology, by Application USD Million (2021-2026)
  • Table 208. Germany Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 209. Germany Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 210. Germany Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 211. France Cryonics Technology, by Application USD Million (2021-2026)
  • Table 212. France Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 213. France Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 214. France Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 215. Italy Cryonics Technology, by Application USD Million (2021-2026)
  • Table 216. Italy Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 217. Italy Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 218. Italy Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 219. United Kingdom Cryonics Technology, by Application USD Million (2021-2026)
  • Table 220. United Kingdom Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 221. United Kingdom Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 222. United Kingdom Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 223. Netherlands Cryonics Technology, by Application USD Million (2021-2026)
  • Table 224. Netherlands Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 225. Netherlands Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 226. Netherlands Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 227. Rest of Europe Cryonics Technology, by Application USD Million (2021-2026)
  • Table 228. Rest of Europe Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 229. Rest of Europe Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 230. Rest of Europe Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 231. MEA Cryonics Technology, by Country USD Million (2021-2026)
  • Table 232. MEA Cryonics Technology, by Application USD Million (2021-2026)
  • Table 233. MEA Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 234. MEA Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 235. MEA Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 236. Middle East Cryonics Technology, by Application USD Million (2021-2026)
  • Table 237. Middle East Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 238. Middle East Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 239. Middle East Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 240. Africa Cryonics Technology, by Application USD Million (2021-2026)
  • Table 241. Africa Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 242. Africa Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 243. Africa Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 244. North America Cryonics Technology, by Country USD Million (2021-2026)
  • Table 245. North America Cryonics Technology, by Application USD Million (2021-2026)
  • Table 246. North America Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 247. North America Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 248. North America Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 249. United States Cryonics Technology, by Application USD Million (2021-2026)
  • Table 250. United States Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 251. United States Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 252. United States Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 253. Canada Cryonics Technology, by Application USD Million (2021-2026)
  • Table 254. Canada Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 255. Canada Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 256. Canada Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 257. Mexico Cryonics Technology, by Application USD Million (2021-2026)
  • Table 258. Mexico Cryonics Technology, by By End User USD Million (2021-2026)
  • Table 259. Mexico Cryonics Technology, by By Methods USD Million (2021-2026)
  • Table 260. Mexico Cryonics Technology, by By Cryoprotective Agent USD Million (2021-2026)
  • Table 261. Research Programs/Design for This Report
  • Table 262. Key Data Information from Secondary Sources
  • Table 263. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cryonics Technology: by Application USD Million (2015-2020)
  • Figure 5. Global Cryonics Technology: by By End User USD Million (2015-2020)
  • Figure 6. Global Cryonics Technology: by By Methods USD Million (2015-2020)
  • Figure 7. Global Cryonics Technology: by By Cryoprotective Agent USD Million (2015-2020)
  • Figure 8. South America Cryonics Technology Share (%), by Country
  • Figure 9. Asia Pacific Cryonics Technology Share (%), by Country
  • Figure 10. Europe Cryonics Technology Share (%), by Country
  • Figure 11. MEA Cryonics Technology Share (%), by Country
  • Figure 12. North America Cryonics Technology Share (%), by Country
  • Figure 13. Global Cryonics Technology share by Players 2020 (%)
  • Figure 14. Global Cryonics Technology share by Players (Top 3) 2020(%)
  • Figure 15. Global Cryonics Technology share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Cellulis (Spain) Revenue, Net Income and Gross profit
  • Figure 18. Cellulis (Spain) Revenue: by Geography 2020
  • Figure 19. Cryofab (United States) Revenue, Net Income and Gross profit
  • Figure 20. Cryofab (United States) Revenue: by Geography 2020
  • Figure 21. Cryologics (United States) Revenue, Net Income and Gross profit
  • Figure 22. Cryologics (United States) Revenue: by Geography 2020
  • Figure 23. Cryotherm (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Cryotherm (Germany) Revenue: by Geography 2020
  • Figure 25. Custom Biogenic Systems (United States) Revenue, Net Income and Gross profit
  • Figure 26. Custom Biogenic Systems (United States) Revenue: by Geography 2020
  • Figure 27. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 28. GE Healthcare (United States) Revenue: by Geography 2020
  • Figure 29. Panasonic Biomedical (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Panasonic Biomedical (Japan) Revenue: by Geography 2020
  • Figure 31. PBS Group (United States) Revenue, Net Income and Gross profit
  • Figure 32. PBS Group (United States) Revenue: by Geography 2020
  • Figure 33. Praxair Technology (United States) Revenue, Net Income and Gross profit
  • Figure 34. Praxair Technology (United States) Revenue: by Geography 2020
  • Figure 35. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 36. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 37. Global Cryonics Technology: by Application USD Million (2021-2026)
  • Figure 38. Global Cryonics Technology: by By End User USD Million (2021-2026)
  • Figure 39. Global Cryonics Technology: by By Methods USD Million (2021-2026)
  • Figure 40. Global Cryonics Technology: by By Cryoprotective Agent USD Million (2021-2026)
  • Figure 41. South America Cryonics Technology Share (%), by Country
  • Figure 42. Asia Pacific Cryonics Technology Share (%), by Country
  • Figure 43. Europe Cryonics Technology Share (%), by Country
  • Figure 44. MEA Cryonics Technology Share (%), by Country
  • Figure 45. North America Cryonics Technology Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Cellulis (Spain)
  • Cryofab (United States)
  • Cryologics (United States)
  • Cryotherm (Germany)
  • Custom Biogenic Systems (United States)
  • GE Healthcare (United States)
  • Panasonic Biomedical (Japan)
  • PBS Group (United States)
  • Praxair Technology (United States)
  • Thermo Fisher Scientific (United States)
Additional players considered in the study are as follows:
KrioRus (Russia) , Oregon Cryonics (United States) , VWR (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation